BiotechTube
Home/Pipeline/Jaythari (deflazacort)

Jaythari (deflazacort)

Not specified

CommercialMarketed

Key Facts

Indication
Not specified
Phase
Commercial
Status
Marketed
Company
Zydus Cadila

About Zydus Cadila

A global, fully integrated pharmaceutical company developing and manufacturing generic medicines, small molecules, biologics, and vaccines across multiple therapeutic areas.

View full company profile

Therapeutic Areas

OncologyCardiovascularInfectious DiseaseDermatologyNeurologyImmunology

Other Not specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved